共 6 条
The structure of Escherichia coli ATP-phosphoribosyltransferase:: Identification of substrate binding sites and mode of AMP inhibition
被引:45
|作者:
Lohkamp, B
McDermott, G
Campbell, SA
Coggins, JR
Lapthorn, AJ
[1
]
机构:
[1] Univ Glasgow, Dept Chem, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[2] Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA
[3] Univ Strathclyde, Dept Immunol, Glasgow G4 0NR, Lanark, Scotland
基金:
英国惠康基金;
关键词:
ATP-phosphoribosyltransferase;
histidine biosynthesis;
crystal structure;
PRPP binding;
AMP inhibition;
D O I:
10.1016/j.jmb.2003.12.020
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
ATP-phosphoribosyltransferase (ATP-PRT), the first enzyme of the histidine pathway, is a complex allosterically regulated enzyme, which controls the flow of intermediates through this biosynthetic pathway. The crystal structures of Escherichia coli ATP-PRT have been solved in complex with the inhibitor AMP at 2.7 Angstrom and with product PR-ATP at 2.9 Angstrom (the ribosyl-triphosphate could not be resolved). On the basis of binding of AMP and PR-ATP and comparison with type I PRTs, the PRPP and parts of the ATP-binding site are identified. These structures clearly identify the AMP as binding in the 5-phosphoribosyl-alpha-1-pyrophosphate (PRPP)binding site, with the adenosine ring occupying the ATP-binding site. Comparison with the recently solved Mycobacterium tuberculosis ATP-PRT structures indicates that histidine is solely responsible for the large conformational changes observed between the hexameric forms of the enzyme. The role of oligomerisation in inhibition and the structural basis for the synergistic inhibition by histidine and AMP are discussed. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:131 / 144
页数:14
相关论文